Skip to main content

Thrive Capital Management, LLC

SEC CIK
0001845943
Latest filing
Aug 5, 2026

The latest 13F from Thrive Capital Management, LLC covers Q2 2026 (filed Aug 5, 2026): 170 long positions worth $530.5M. The top 10 holdings make up 26.7% of the portfolio, and the largest is Invesco QQQ Trust Series I at 5.4%. Livermore has 22 filings on Form 13F from this institution, going back to Q1 2021.

What changed in Q2 2026

Share counts compared with Q1 2026: how many positions were new, added to, reduced or sold out, and the biggest buys and sells. Dollar amounts are estimated at the quarter-end prices implied by the filing.

Full comparison
New
16
Est. +$17.8M
Added
81
Est. +$68.5M
Reduced
67
Est. −$26.3M
Sold out
15
Est. −$25.9M

Top 5 holdings

Share of this quarter's portfolio value

  1. Invesco QQQ Trust Series I46090E103
    5.4%$28.8M
  2. Vanguard Ftse Developed Markets ETF921943858
    3.0%$15.8M
  3. Vanguard Morningstar Growth ETF922908736
    2.8%$15.0M
  4. Vanguard S&P 500 ETF922908363
    2.7%$14.5M
  5. Vanguard Morningstar Value ETF922908744
    2.6%$13.8M

Share of portfolio

Top 5 holdings and the other 165 positions, by share of portfolio value

  1. Invesco QQQ Trust Series I5.4%
  2. Vanguard Ftse Developed Markets ETF3.0%
  3. Vanguard Morningstar Growth ETF2.8%
  4. Vanguard S&P 500 ETF2.7%
  5. Vanguard Morningstar Value ETF2.6%
  6. Other 165 positions83.5%

Biggest buys

New and added positions, by estimated amount bought

  1. Invesco QQQ Trust Series I46090E103
    +$9.69MAdded
  2. PGRProgressive Corp
    +$4.90MNewHistory
  3. AMDAdvanced Micro Devices Inc
    +$4.75MAddedHistory
  4. VVisa Inc.
    +$4.48MAddedHistory
  5. UHSUniversal Health Services Inc
    +$4.43MNewHistory

Largest weight increases

New and added positions, by percentage points of the portfolio gained

  1. Invesco QQQ Trust Series I46090E103
    +2.15 pp3.3% → 5.4%
  2. AMDAdvanced Micro Devices Inc
    +1.19 pp0.2% → 1.4%History
  3. PGRProgressive Corp
    +0.92 pp0.0% → 0.9%History
  4. VVisa Inc.
    +0.84 pp0.1% → 0.9%History
  5. UHSUniversal Health Services Inc
    +0.84 pp0.0% → 0.8%History

Biggest sells

Reduced and sold-out positions, by estimated amount sold

  1. MUMicron Technology Inc
    −$5.27MReducedHistory
  2. FOXAFox Corp
    −$4.59MSold outHistory
  3. HIMSHims & Hers Health, Inc.
    −$4.54MSold outHistory
  4. FLEXFlex Ltd.
    −$4.50MReducedHistory
  5. CAGConagra Brands Inc.
    −$3.71MSold outHistory

Largest weight decreases

Reduced and sold-out positions, by percentage points of the portfolio lost

  1. FOXAFox Corp
    −1.01 pp1.0% → 0.0%History
  2. HIMSHims & Hers Health, Inc.
    −1.00 pp1.0% → 0.0%History
  3. CAGConagra Brands Inc.
    −0.81 pp0.8% → 0.0%History
  4. ABTAbbott Laboratories
    −0.74 pp0.7% → 0.0%History
  5. PHMPultegroup Inc
    −0.73 pp0.7% → 0.0%History

Metrics

13F metrics for Q2 2026, computed only from the numbers in the filings. Definitions below.

Portfolio value
$530.5M
+$74.2M (+16.3%) vs. prior quarter
Positions
170
+1 vs. prior quarter
Top 10 concentration
26.7%
Top 10 as share of value
Turnover
10.6%
Q2 2026, one quarter
Average holding period
7.5 quarters
Weighted by value

How these are calculated

  • Portfolio value: the market value of all long positions in the 13F, as reported at quarter end, excluding options.
  • Top 10 concentration: the combined value of the 10 largest positions as a share of portfolio value.
  • Turnover: the smaller of this quarter's estimated purchases and estimated sales, divided by the average of this and last quarter's portfolio value. Estimates multiply the change in shares by the quarter-end price implied by the filing (market value divided by shares); new positions use this quarter's value and sold-out positions last quarter's. Only positions reported in shares count, and it is not calculated when the previous quarter was not filed.
  • Average holding period: how many consecutive quarters each current position has been held (including this one; a quarter without the position or without a filing starts the count over), weighted by this quarter's value. Counting starts with the first 13F in Livermore (Q1 2021), so positions held before then are understated.

13F filings by quarter

22 quarters, going back to Q1 2021. Bars show each quarter's 13F portfolio value; quarters without a filing are left blank.

Peak $530.5M (Q2 2026)

Q1 2021: $107.0MQ2 2021: $128.6MQ3 2021: $135.4MQ4 2021: $153.5MQ1 2022: $165.7MQ2 2022: $144.4MQ3 2022: $147.8MQ4 2022: $152.9MQ1 2023: $158.5MQ2 2023: $175.3MQ3 2023: $180.4MQ4 2023: $186.9MQ1 2024: $187.7MQ2 2024: $218.8MQ3 2024: $212.3MQ4 2024: $218.2MQ1 2025: $167.4MQ2 2025: $319.3MQ3 2025: $387.7MQ4 2025: $449.0MQ1 2026: $456.3MQ2 2026: $530.5M
Q1 2021Q2 2026
13F filings of Thrive Capital Management, LLC by quarter
QuarterFiledPositionsValueTop 3 holdingsChangesFiling
Q2 2026Aug 5, 2026170$530.5MInvesco QQQ Trust Series IVanguard Ftse Developed Markets ETFVanguard Morningstar Growth ETFvs. Q1 2026SEC
Q1 2026Apr 27, 2026169$456.3MInvesco QQQ Trust Series IVanguard Ftse Developed Markets ETFVanguard Ftse Emerging Markets ETFvs. Q4 2025SEC
Q4 2025Feb 9, 2026174$449.0MInvesco QQQ Trust Series IVanguard Ftse Developed Markets ETFVanguard Morningstar Growth ETFvs. Q3 2025SEC
Q3 2025Oct 28, 2025171$387.7MInvesco QQQ Trust Series IVanguard Morningstar Growth ETFVanguard Ftse Developed Markets ETFvs. Q2 2025SEC
Q2 2025Aug 8, 2025169$319.3MInvesco QQQ Trust Series IVanguard Morningstar Growth ETFVanguard Morningstar Mid-Cap Growth ETFvs. Q1 2025SEC
Q1 2025Apr 30, 2025114$167.4MiShares TrVanguard Index FDSState Street SPDR S&P Aerospace & Defense ETFvs. Q4 2024SEC
Q4 2024Feb 13, 202596$218.2MiShares Core Dividend Growth ETFVanguard Morningstar Growth ETFVanguard Morningstar Value ETFvs. Q3 2024SEC
Q3 2024Nov 13, 2024177$212.3MiShares Core Dividend Growth ETFiShares TrVanguard High Dividend Yield Index ETFvs. Q2 2024SEC
Q2 2024Aug 9, 2024179$218.8MiShares Core Dividend Growth ETFVanguard High Dividend Yield Index ETFiShares Trvs. Q1 2024SEC
Q1 2024May 13, 2024120$187.7MiShares TrSPDR Series TrustVanguard S&P 500 ETFvs. Q4 2023SEC
Q4 2023Jan 29, 2024156$186.9MiShares Core Dividend Growth ETFVanguard High Dividend Yield Index ETFState Street SPDR Portfolio S&P 500 Growth ETFvs. Q3 2023SEC
Q3 2023Nov 2, 2023137$180.4MiShares Core Dividend Growth ETFVanguard High Dividend Yield Index ETFState Street SPDR Portfolio S&P 500 Growth ETFvs. Q2 2023SEC
Q2 2023Aug 2, 2023136$175.3MiShares Core Dividend Growth ETFVanguard High Dividend Yield Index ETFState Street SPDR Portfolio S&P 500 Growth ETFvs. Q1 2023SEC
Q1 2023May 8, 2023121$158.5MiShares Core Dividend Growth ETFiShares TrState Street SPDR Portfolio S&P 500 Growth ETFvs. Q4 2022SEC
Q4 2022Jan 19, 2023113$152.9MiShares Core Dividend Growth ETFiShares TrState Street SPDR Portfolio S&P 500 Growth ETFvs. Q3 2022SEC
Q3 2022Nov 9, 2022112$147.8MiShares Core Dividend Growth ETFiShares TrState Street SPDR Portfolio S&P 500 Growth ETFvs. Q2 2022SEC
Q2 2022Aug 8, 2022102$144.4MiShares Core Dividend Growth ETFiShares TrState Street SPDR Portfolio S&P 500 Growth ETFvs. Q1 2022SEC
Q1 2022May 6, 202297$165.7MState Street SPDR Portfolio S&P 500 Growth ETFiShares TriShares Core Dividend Growth ETFvs. Q4 2021SEC
Q4 2021Feb 9, 2022101$153.5MState Street SPDR Portfolio S&P 500 Growth ETFiShares TriShares U.S. Treasury Bond ETFvs. Q3 2021SEC
Q3 2021Nov 12, 2021107$135.4MState Street SPDR Portfolio S&P 500 Growth ETFiShares TriShares U.S. Treasury Bond ETFvs. Q2 2021SEC
Q2 2021Aug 6, 2021109$128.6MiShares TrState Street SPDR Portfolio S&P 500 Growth ETFiShares U.S. Treasury Bond ETFvs. Q1 2021SEC
Q1 2021May 10, 2021106$107.0MiShares U S ETF TriShares TriShares Tr–SEC